RxDoctor Payments Data

Dennis Thomas

Cardiovascular Disease · Mobile, ALNPI 1831344217

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $891,272 of the $893,522 with a category attached, or 99.7%. 3 manufacturers reported payments, led by Kedplasma LLC at 44.2% of the total. Among cardiovascular disease clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$893,522in general payments, 2019–2025

Across 528 payments — averaging $1692.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kedplasma LLC$395K
  • CSL Plasma Inc.$325K
  • CSL Behring$174K

What the payments were for

  • Consulting fees$891,272100%
  • Travel & lodging$2,2500%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Kedplasma LLC172$394,501
CSL Plasma Inc.217$324,669
CSL Behring139$174,353

How this compares

$893,522 in reported general payments places this provider in the 95th percentile of 292 cardiovascular disease providers in Alabama.

See all cardiovascular disease providers in Alabama →

Other cardiovascular disease in Mobile

See the full list for Alabama →

Where these figures come from

Is this you, or does something look wrong? →